Moderna Shares Mark New Session Low Under $320 Level, Now Down 11%; Recent Reuters Article Highlighting Potential Implication Of Earlier Patent Ruling 'Moderna could be sued over vaccines as court upholds patents'

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!